Stephanie Jinyu Yaung from 1137 Queensbridge Way, San Jose, CA 95120, age 37, Phone: 408 239-6925

Us Patents

Method Of Monitoring Effectiveness Of Immunotherapy Of Cancer Patients
view source
US Patent:

20210292851, Sep 23, 2021
Filed:

Jul 29, 2019
Appl. No.:

17/263708
Inventors:

- Pleasanton CA, US
- South San Francisco CA, US
John Palma - Alamo CA, US
Namrata Patil - South San Francisco CA, US
Johnny Wu - Castro Valley CA, US
Stephanie Yaung - San Jose CA, US
Wei Zou - San Carlos CA, US
International Classification:

C12Q 1/6886
C12Q 1/6869
Abstract:

The invention is a method of determining a likelihood that a cancer patient will respond to immunotherapy based on a mutation metric obtained by sequencing a small panel of nucleic acid targets in patient's cell-free DNA.

Method Of Cancer Prognosis By Assessing Tumor Variant Diversity
view source
US Patent:

20210222251, Jul 22, 2021
Filed:

May 8, 2019
Appl. No.:

17/053734
Inventors:

- Pleasanton CA, US
Felix HERTH - Heidelberg, DE
Christine JU - Pleasanton CA, US
Xiaoju MA - San Carlos CA, US
Thomas MULEY - Heidelberg, DE
Birgit WEHNL - Munich, DE
Liu XI - Fremont CA, US
Stephanie J. YAUNG - San Jose CA, US
Assignee:

Roche Sequencing Solutions, Inc. - Pleasanton CA
International Classification:

C12Q 1/6886
Abstract:

The invention is a method of predicting response to therapy in a colorectal cancer patient, the method comprising measuring tumor genetic heterogeneity via analysis of circulating tumor DNA from a patient's sample.

Surrogate Marker And Method For Tumor Mutation Burden Measurement
view source
US Patent:

20210054465, Feb 25, 2021
Filed:

May 3, 2019
Appl. No.:

17/052142
Inventors:

- Pleasanton CA, US
Christine Ju - Pleasanton CA, US
Xiaoju Ma - San Carlos CA, US
Thomas Muley - Heidelberg, DE
Felix Herth - Heidelberg, DE
Nalin Tikoo - San Ramon CA, US
Birgit Wehnl - Munich, DE
Liu Xi - Fremont CA, US
Stephanie J. Yaung - San Jose CA, US
Amrita Pati - San Ramon CA, US
International Classification:

C12Q 1/6886
C07K 16/28
Abstract:

The invention is a method of predicting recurrence of colorectal cancer in a patient following surgery, the method comprising analysis of circulating tumor DNA from a patient's sample.

Method Of Predicting Response To Therapy By Assessing Tumor Genetic Heterogeneity
view source
US Patent:

20210002719, Jan 7, 2021
Filed:

Feb 11, 2019
Appl. No.:

16/968811
Inventors:

- Pleasanton CA, US
John J. Lee - Walnut Creek CA, US
John F. Palma - Alamo CA, US
Stephanie J. Yaung - San Jose CA, US
International Classification:

C12Q 1/6869
G16H 50/30
A61K 31/4745
Abstract:

The invention is a method of predicting response to therapy in a colorectal cancer patient, the method comprising measuring tumor genetic heterogeneity via analysis of circulating tumor DNA from a patient's sample.

Method Of Predicting Response To Therapy By Assessing Tumor Genetic Heterogeneity
view source
US Patent:

20200399711, Dec 24, 2020
Filed:

Feb 11, 2019
Appl. No.:

16/969172
Inventors:

- Pleasanton CA, US
Christine Ju - Pleasanton CA, US
Xiaoju Ma - San Carlos CA, US
Thomas Muley - Heidelberg, DE
Felix Herth - Heidelberg, DE
Nalin Tikoo - San Ramon CA, US
Birgit Wehnl - Muenchen, DE
Liu Xi - Fremont CA, US
Stephanie J. Yaung - San Jose CA, US
International Classification:

C12Q 1/6886
Abstract:

The invention is a method of predicting response to therapy in a cancer patient by serial sampling the patient's cell-free tumor nucleic acids to determine a change in the number of mutations per amount of plasma.

Non-Invasive Test To Predict Response To Therapy In Colorectal Cancer Patients
view source
US Patent:

20190360060, Nov 28, 2019
Filed:

Aug 7, 2019
Appl. No.:

16/534272
Inventors:

- Pleasanton CA, US
John Palma - Alamo CA, US
Ulrich-Peter Rohr - Loerrach, DE
Lijing Yao - Foster City CA, US
Stephanie Yaung - San Jose CA, US
International Classification:

C12Q 1/6886
G16B 20/20
Abstract:

The invention is a method of predicting response to therapy in a colorectal cancer patient, the method comprising analysis of circulating tumor DNA from a patient's sample.

Novel Mutations In Anaplastic Lymphoma Kinase Predicting Response To Alk Inhibitor Therapy In Lung Cancer Patients
view source
US Patent:

20170349953, Dec 7, 2017
Filed:

Jun 1, 2017
Appl. No.:

15/611612
Inventors:

- Pleasanton CA, US
Stephanie Yaung - San Jose CA, US
Aarthi Balasubramanyam - Sunnyvale CA, US
John Palma - Alamo CA, US
International Classification:

C12Q 1/68
A61K 39/00
Abstract:

The invention comprises novel methods and compositions for detecting whether a patient will be responsive to ALK inhibitors and methods of treating the patient.

Precise Microbiota Engineering At The Cellular Level
view source
US Patent:

20160348120, Dec 1, 2016
Filed:

Nov 5, 2014
Appl. No.:

15/034682
Inventors:

- Cambridge MA, US
Stephanie Yaung - San Jose CA, US
Assignee:

President and Fellows of Harvard College - Cambridge MA
International Classification:

C12N 15/70
A61K 35/74
C12N 15/90
Abstract:

Stably immunized cells and methods of making stably immunized cells are provided. Methods of altering the microbiota of an ecological environment are provided. Methods of modifying target chromosomes are provided. Methods of delivering genetic material to target cells are provided.

Resumes

Senior Manager, Medical Affairs

view source

Location:

1137 Queensbridge Way, San Jose, CA 95120

Industry:

Biotechnology

Work:

Wyss Institute for Biologically Inspired Engineering - Greater Boston Area since Jan 2011
Graduate Student
Harvard Medical School - Greater Boston Area since Nov 2010
Graduate Researcher, George Church Lab
Genentech - San Francisco Bay Area Jun 2010 - Aug 2010
Late Stage Pharmaceutical and Processing Development Intern
Merck - Greater New York City Area Jun 2009 - Aug 2009
Analytical Development & Commercialization Intern and Engineering & Technology Fellow
Roche Pharmaceuticals - San Francisco Bay Area Jun 2008 - Mar 2009
Investigative Toxicology Intern

Education:

Harvard-MIT Division of Health Sciences & Technology 2010 - 2015
MIT Sloan School of Management 2006 - 2010
Massachusetts Institute of Technology 2006 - 2010
Leland High School 2002 - 2006

Skills:

Biotechnology
Molecular Biology
Protein Chemistry
Cell Biology
Genetics
Cell
Assay Development
Bioinformatics
Cell Culture
Microbiology
Research
Matlab
Lifesciences
Laboratory
Life Sciences
Statistics
Microscopy
Genomics
Stem Cells
R
Python
Bioengineering
Toxicology
Entrepreneurship
Market Research
Programming
Perl
Java
Html
Mentoring
Data Visualization
Team Leadership

Interests:

Exercise
Nascar
Home Improvement
Reading
Sports
The Arts
Home Decoration
Health
Cooking
Electronics
Outdoors
Education
Crafts
Fitness
Family Values
Collecting
Christianity
Kids
Medicine
Travel
Boating
Investing
Traveling

Languages:

English
Mandarin
Spanish
German

Stephanie Yaung

view source

Stephanie Jinyu Yaung

Stephanie Yaung Phones & Addresses

Education

Us Patents

Method Of Monitoring Effectiveness Of Immunotherapy Of Cancer Patients

Method Of Cancer Prognosis By Assessing Tumor Variant Diversity

Surrogate Marker And Method For Tumor Mutation Burden Measurement

Method Of Predicting Response To Therapy By Assessing Tumor Genetic Heterogeneity

Method Of Predicting Response To Therapy By Assessing Tumor Genetic Heterogeneity

Non-Invasive Test To Predict Response To Therapy In Colorectal Cancer Patients

Novel Mutations In Anaplastic Lymphoma Kinase Predicting Response To Alk Inhibitor Therapy In Lung Cancer Patients

Precise Microbiota Engineering At The Cellular Level

Resumes

Senior Manager, Medical Affairs

Stephanie Yaung

Youtube

The Killers-When You Were Young

Carieke's School of Highland Dancing, Caledonia

Googleplus

Stephanie Yaung

Facebook

Stephanie Yaung